RT Journal Article
SR Electronic
A1 Buckley, Rita
T1 Liraglutide Reduces Insulin Dose without Affecting Glycemic Control in T1DM
JF MD Conference Express
YR 2011
FD SAGE Publications
VO 11
IS 11
SP 17
OP 20
DO 10.1177/155989771111012
UL http://mdc.sagepub.com/content/11/11/17.abstract
AB This article reports on results from a 4-week randomized, open-label efficacy trial on the effects of treatment with liraglutide, a once-daily human GLP-1 receptor analog, on insulin dose and glycemic control in patients with type 1 diabetes mellitus with and without residual β-cell function [NCT00993720; Kielgast U et al. Diabetes Care 2011].